125 related articles for article (PubMed ID: 18759452)
1. P-glycoprotein senses its substrates and the lateral membrane packing density: consequences for the catalytic cycle.
Aänismaa P; Gatlik-Landwojtowicz E; Seelig A
Biochemistry; 2008 Sep; 47(38):10197-207. PubMed ID: 18759452
[TBL] [Abstract][Full Text] [Related]
2. P-Glycoprotein kinetics measured in plasma membrane vesicles and living cells.
Aänismaa P; Seelig A
Biochemistry; 2007 Mar; 46(11):3394-404. PubMed ID: 17302433
[TBL] [Abstract][Full Text] [Related]
3. The rate of P-glycoprotein activation depends on the metabolic state of the cell.
Gatlik-Landwojtowicz E; Aänismaa P; Seelig A
Biochemistry; 2004 Nov; 43(46):14840-51. PubMed ID: 15544355
[TBL] [Abstract][Full Text] [Related]
4. Quantification and characterization of P-glycoprotein-substrate interactions.
Gatlik-Landwojtowicz E; Aänismaa P; Seelig A
Biochemistry; 2006 Mar; 45(9):3020-32. PubMed ID: 16503657
[TBL] [Abstract][Full Text] [Related]
5. The membrane lipid environment modulates drug interactions with the P-glycoprotein multidrug transporter.
Romsicki Y; Sharom FJ
Biochemistry; 1999 May; 38(21):6887-96. PubMed ID: 10346910
[TBL] [Abstract][Full Text] [Related]
6. The multidrug transporter, P-glycoprotein, actively mediates cholesterol redistribution in the cell membrane.
Garrigues A; Escargueil AE; Orlowski S
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10347-52. PubMed ID: 12145328
[TBL] [Abstract][Full Text] [Related]
7. First characterization of fish P-glycoprotein (abcb1) substrate specificity using determinations of its ATPase activity and calcein-AM assay with PLHC-1/dox cell line.
Zaja R; Lončar J; Popovic M; Smital T
Aquat Toxicol; 2011 May; 103(1-2):53-62. PubMed ID: 21392495
[TBL] [Abstract][Full Text] [Related]
8. Improved energy coupling of human P-glycoprotein by the glycine 185 to valine mutation.
Omote H; Figler RA; Polar MK; Al-Shawi MK
Biochemistry; 2004 Apr; 43(13):3917-28. PubMed ID: 15049699
[TBL] [Abstract][Full Text] [Related]
9. [Energy characteristics of an ATP-hydrolase reaction catalyzed by solubilized Ca2+,Mg2+-ATPase from smooth muscle cell membrane].
Kosterin SA; Slinchenko NN; Gergalova GL
Biokhimiia; 1994 Jun; 59(6):889-904. PubMed ID: 8075253
[TBL] [Abstract][Full Text] [Related]
10. P-glycoprotein substrate transport assessed by comparing cellular and vesicular ATPase activity.
Nervi P; Li-Blatter X; Aänismaa P; Seelig A
Biochim Biophys Acta; 2010 Mar; 1798(3):515-25. PubMed ID: 20004641
[TBL] [Abstract][Full Text] [Related]
11. Transmembrane segment 7 of human P-glycoprotein forms part of the drug-binding pocket.
Loo TW; Bartlett MC; Clarke DM
Biochem J; 2006 Oct; 399(2):351-9. PubMed ID: 16813563
[TBL] [Abstract][Full Text] [Related]
12. Detergents as intrinsic P-glycoprotein substrates and inhibitors.
Li-Blatter X; Nervi P; Seelig A
Biochim Biophys Acta; 2009 Oct; 1788(10):2335-44. PubMed ID: 19631191
[TBL] [Abstract][Full Text] [Related]
13. Absence of cooperativity for MgATP and verapamil effects on the ATPase activity of P-glycoprotein containing membrane vesicles.
Garrigos M; Belehradek J; Mir LM; Orlowski S
Biochem Biophys Res Commun; 1993 Nov; 196(3):1034-41. PubMed ID: 7902705
[TBL] [Abstract][Full Text] [Related]
14. A high-throughput screening microplate test for the interaction of drugs with P-glycoprotein.
Garrigues A; Nugier J; Orlowski S; Ezan E
Anal Biochem; 2002 Jun; 305(1):106-14. PubMed ID: 12018951
[TBL] [Abstract][Full Text] [Related]
15. ATP occlusion by P-glycoprotein as a surrogate measure for drug coupling.
Tombline G; Holt JJ; Gannon MK; Donnelly DJ; Wetzel B; Sawada GA; Raub TJ; Detty MR
Biochemistry; 2008 Mar; 47(10):3294-307. PubMed ID: 18275155
[TBL] [Abstract][Full Text] [Related]
16. Quantitative structure--activity relationship analysis and molecular dynamics simulation to functionally validate nonsynonymous polymorphisms of human ABC transporter ABCB1 (P-glycoprotein/MDR1).
Sakurai A; Onishi Y; Hirano H; Seigneuret M; Obanayama K; Kim G; Liew EL; Sakaeda T; Yoshiura K; Niikawa N; Sakurai M; Ishikawa T
Biochemistry; 2007 Jul; 46(26):7678-93. PubMed ID: 17559192
[TBL] [Abstract][Full Text] [Related]
17. Protein concentration and pH affect the apparent P-glycoprotein-ATPase activation kinetics.
Heikkinen AT; Mönkkönen J
Int J Pharm; 2008 Jan; 346(1-2):169-72. PubMed ID: 17624702
[TBL] [Abstract][Full Text] [Related]
18. P-glycoprotein does not actively transport nicotine and cotinine.
Wang JS; Markowitz JS; Donovan JL; Devane CL
Addict Biol; 2005 Jun; 10(2):127-9. PubMed ID: 16191663
[TBL] [Abstract][Full Text] [Related]
19. P-glycoprotein ATPase activating effect of opioid analgesics and their P-glycoprotein-dependent antinociception in mice.
Hamabe W; Maeda T; Fukazawa Y; Kumamoto K; Shang LQ; Yamamoto A; Yamamoto C; Tokuyama S; Kishioka S
Pharmacol Biochem Behav; 2006 Nov; 85(3):629-36. PubMed ID: 17134744
[TBL] [Abstract][Full Text] [Related]
20. In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system.
Feng B; Mills JB; Davidson RE; Mireles RJ; Janiszewski JS; Troutman MD; de Morais SM
Drug Metab Dispos; 2008 Feb; 36(2):268-75. PubMed ID: 17962372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
